IRLAB Therapeutics (Sweden) Buy Hold or Sell Recommendation
| IRLAB-A Stock | SEK 14.10 0.40 2.76% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding IRLAB Therapeutics AB is 'Strong Hold'. Macroaxis provides IRLAB Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IRLAB-A positions.
Check out IRLAB Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as IRLAB and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards IRLAB Therapeutics AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
IRLAB |
Execute IRLAB Therapeutics Buy or Sell Advice
The IRLAB recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on IRLAB Therapeutics AB. Macroaxis does not own or have any residual interests in IRLAB Therapeutics AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute IRLAB Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
30 Days |
Risk Tolerance
I am an educated risk taker |
 |  |
Strong Hold
Market Performance | Insignificant | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
IRLAB Therapeutics Trading Alerts and Improvement Suggestions
| IRLAB Therapeutics had very high historical volatility over the last 90 days | |
| About 39.0% of the company shares are held by company insiders |
IRLAB Therapeutics Returns Distribution Density
The distribution of IRLAB Therapeutics' historical returns is an attempt to chart the uncertainty of IRLAB Therapeutics' future price movements. The chart of the probability distribution of IRLAB Therapeutics daily returns describes the distribution of returns around its average expected value. We use IRLAB Therapeutics AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of IRLAB Therapeutics returns is essential to provide solid investment advice for IRLAB Therapeutics.
| Mean Return | 0.39 |
| Value At Risk | -4.71 |
| Potential Upside | 10.83 |
| Standard Deviation | 5.89 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of IRLAB Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
IRLAB Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to IRLAB Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that IRLAB Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a IRLAB stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.40 | |
β | Beta against Dow Jones | 1.01 | |
σ | Overall volatility | 6.07 | |
Ir | Information ratio | 0.07 |
IRLAB Therapeutics Volatility Alert
IRLAB Therapeutics AB shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure IRLAB Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact IRLAB Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.IRLAB Therapeutics Fundamentals Vs Peers
Comparing IRLAB Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze IRLAB Therapeutics' direct or indirect competition across all of the common fundamentals between IRLAB Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as IRLAB Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of IRLAB Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing IRLAB Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare IRLAB Therapeutics to competition |
| Fundamentals | IRLAB Therapeutics | Peer Average |
| Return On Equity | -0.28 | -0.31 |
| Return On Asset | -0.15 | -0.14 |
| Profit Margin | (1.69) % | (1.27) % |
| Operating Margin | (1.68) % | (5.51) % |
| Current Valuation | 1.74 B | 16.62 B |
| Shares Outstanding | 51.79 M | 571.82 M |
| Shares Owned By Insiders | 38.63 % | 10.09 % |
| Shares Owned By Institutions | 22.49 % | 39.21 % |
| Price To Book | 6.24 X | 9.51 X |
| Price To Sales | 33.49 X | 11.42 X |
| Revenue | 207.78 M | 9.43 B |
| Gross Profit | 126.05 M | 27.38 B |
| EBITDA | 55.62 M | 3.9 B |
| Net Income | 51.78 M | 570.98 M |
| Cash And Equivalents | 401.9 M | 2.7 B |
| Cash Per Share | 2.89 X | 5.01 X |
| Total Debt | 3.57 M | 5.32 B |
| Debt To Equity | 2.90 % | 48.70 % |
| Current Ratio | 9.19 X | 2.16 X |
| Book Value Per Share | 6.25 X | 1.93 K |
| Cash Flow From Operations | 128.64 M | 971.22 M |
| Earnings Per Share | 0.81 X | 3.12 X |
| Target Price | 200.0 | |
| Number Of Employees | 31 | 18.84 K |
| Beta | 0.16 | -0.15 |
| Market Capitalization | 525.71 M | 19.03 B |
| Total Asset | 472.45 M | 29.47 B |
| Z Score | 88.2 | 8.72 |
| Net Asset | 472.45 M |
IRLAB Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as IRLAB . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About IRLAB Therapeutics Buy or Sell Advice
When is the right time to buy or sell IRLAB Therapeutics AB? Buying financial instruments such as IRLAB Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having IRLAB Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Emerging Markets Funds Thematic Idea Now
Emerging Markets Funds
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in IRLAB Stock
IRLAB Therapeutics financial ratios help investors to determine whether IRLAB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IRLAB with respect to the benefits of owning IRLAB Therapeutics security.